171 related articles for article (PubMed ID: 38447809)
1. Active immunotherapy for C5a-mediated inflammation using adjuvant-free self-assembled peptide nanofibers.
Hainline KM; Haddad HF; Gilpin A; Curvino EJ; Varghese S; Collier JH
Acta Biomater; 2024 Apr; 179():83-94. PubMed ID: 38447809
[TBL] [Abstract][Full Text] [Related]
2. Active immunotherapy for TNF-mediated inflammation using self-assembled peptide nanofibers.
Mora-Solano C; Wen Y; Han H; Chen J; Chong AS; Miller ML; Pompano RR; Collier JH
Biomaterials; 2017 Dec; 149():1-11. PubMed ID: 28982051
[TBL] [Abstract][Full Text] [Related]
3. Self-assembled peptide nanofibers raising durable antibody responses against a malaria epitope.
Rudra JS; Mishra S; Chong AS; Mitchell RA; Nardin EH; Nussenzweig V; Collier JH
Biomaterials; 2012 Sep; 33(27):6476-84. PubMed ID: 22695068
[TBL] [Abstract][Full Text] [Related]
4. Multifactorial Design of a Supramolecular Peptide Anti-IL-17 Vaccine Toward the Treatment of Psoriasis.
Shores LS; Kelly SH; Hainline KM; Suwanpradid J; MacLeod AS; Collier JH
Front Immunol; 2020; 11():1855. PubMed ID: 32973764
[TBL] [Abstract][Full Text] [Related]
5. Modular complement assemblies for mitigating inflammatory conditions.
Hainline KM; Shores LS; Votaw NL; Bernstein ZJ; Kelly SH; Fries CN; Madhira MS; Gilroy CA; Chilkoti A; Collier JH
Proc Natl Acad Sci U S A; 2021 Apr; 118(15):. PubMed ID: 33876753
[TBL] [Abstract][Full Text] [Related]
6. Active immunization against complement factor C5a: a new therapeutic approach for Alzheimer's disease.
Landlinger C; Oberleitner L; Gruber P; Noiges B; Yatsyk K; Santic R; Mandler M; Staffler G
J Neuroinflammation; 2015 Aug; 12():150. PubMed ID: 26275910
[TBL] [Abstract][Full Text] [Related]
7. Self-Assembly as a Molecular Strategy to Improve Immunotherapy.
Froimchuk E; Carey ST; Edwards C; Jewell CM
Acc Chem Res; 2020 Nov; 53(11):2534-2545. PubMed ID: 33074649
[TBL] [Abstract][Full Text] [Related]
8. A single functional group substitution in c5a breaks B cell and T cell tolerance and protects against experimental arthritis.
Kessel C; Nandakumar KS; Peters FB; Gauba V; Schultz PG; Holmdahl R
Arthritis Rheumatol; 2014 Mar; 66(3):610-21. PubMed ID: 24574221
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of α-helical and β-sheet self-assembled peptide nanofiber vaccine platforms: influence of integrated T-cell epitopes.
Wu Y; Kelly SH; Sanchez-Perez L; Sampson JH; Collier JH
Biomater Sci; 2020 Jun; 8(12):3522-3535. PubMed ID: 32452474
[TBL] [Abstract][Full Text] [Related]
10. Treatment with anti-C5aR mAb leads to early-onset clinical and mechanistic effects in the murine delayed-type hypersensitivity arthritis model.
Atkinson SM; Nansen A; Usher PA; Sondergaard BC; Mackay CR; Friedrichsen B; Chang CC; Tang R; Skov S; Haase C; Hornum L
Autoimmunity; 2015; 48(7):460-70. PubMed ID: 25915570
[TBL] [Abstract][Full Text] [Related]
11. The use of self-adjuvanting nanofiber vaccines to elicit high-affinity B cell responses to peptide antigens without inflammation.
Chen J; Pompano RR; Santiago FW; Maillat L; Sciammas R; Sun T; Han H; Topham DJ; Chong AS; Collier JH
Biomaterials; 2013 Nov; 34(34):8776-85. PubMed ID: 23953841
[TBL] [Abstract][Full Text] [Related]
12. Supramolecular Peptide Self-Assemblies Facilitate Oral Immunization.
Curvino EJ; Woodruff ME; Roe EF; Freire Haddad H; Cordero Alvarado P; Collier JH
ACS Biomater Sci Eng; 2024 May; 10(5):3041-3056. PubMed ID: 38623037
[TBL] [Abstract][Full Text] [Related]
13. Intranasal delivery of adjuvant-free peptide nanofibers elicits resident CD8
Si Y; Wen Y; Kelly SH; Chong AS; Collier JH
J Control Release; 2018 Jul; 282():120-130. PubMed ID: 29673645
[TBL] [Abstract][Full Text] [Related]
14. A recombinant vaccine effectively induces c5a-specific neutralizing antibodies and prevents arthritis.
Nandakumar KS; Jansson A; Xu B; Rydell N; Ahooghalandari P; Hellman L; Blom AM; Holmdahl R
PLoS One; 2010 Oct; 5(10):e13511. PubMed ID: 20975959
[TBL] [Abstract][Full Text] [Related]
15. Complement activation pathways in murine immune complex-induced arthritis and in C3a and C5a generation in vitro.
Banda NK; Levitt B; Wood AK; Takahashi K; Stahl GL; Holers VM; Arend WP
Clin Exp Immunol; 2010 Jan; 159(1):100-8. PubMed ID: 19843088
[TBL] [Abstract][Full Text] [Related]
16. Pre-neutralization of C5a-mediated effects by the monoclonal antibody 137-26 reacting with the C5a moiety of native C5 without preventing C5 cleavage.
Fung M; Lu M; Fure H; Sun W; Sun C; Shi NY; Dou Y; Su J; Swanson X; Mollnes TE
Clin Exp Immunol; 2003 Aug; 133(2):160-9. PubMed ID: 12869020
[TBL] [Abstract][Full Text] [Related]
17. Thermal stability of self-assembled peptide vaccine materials.
Sun T; Han H; Hudalla GA; Wen Y; Pompano RR; Collier JH
Acta Biomater; 2016 Jan; 30():62-71. PubMed ID: 26584836
[TBL] [Abstract][Full Text] [Related]
18. Self-Assembled Nanofibers Elicit Potent HPV16 E7-Specific Cellular Immunity And Abolish Established TC-1 Graft Tumor.
Li S; Zhang Q; Bai H; Huang W; Shu C; Ye C; Sun W; Ma Y
Int J Nanomedicine; 2019; 14():8209-8219. PubMed ID: 31632028
[TBL] [Abstract][Full Text] [Related]
19. Antigenic peptide nanofibers elicit adjuvant-free CD8⁺ T cell responses.
Chesson CB; Huelsmann EJ; Lacek AT; Kohlhapp FJ; Webb MF; Nabatiyan A; Zloza A; Rudra JS
Vaccine; 2014 Feb; 32(10):1174-80. PubMed ID: 24308959
[TBL] [Abstract][Full Text] [Related]
20. Inhibiting the C5-C5a receptor axis.
Woodruff TM; Nandakumar KS; Tedesco F
Mol Immunol; 2011 Aug; 48(14):1631-42. PubMed ID: 21549429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
